Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 5 | Critical Care

Figure 5

From: Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection

Figure 5

Inhibition or deletion of receptor for advanced glycation end products (RAGE) does not disrupt the host mechanism for clearance of Listeria monocytogenes. Quantitative levels of L. monocytogenes in organ samples (liver and spleen, n = 10 per group) 48 hours after an intraperitoneal injection of 104 colony-forming units (CFU) per animal (P < 0.001 anti-tumor necrosis factor [TNF] monoclonal antibody [mAb] group versus all other groups).

Back to article page